Search Results - "Rizvi, Yasmeen"

The simultaneous effect of green ability-motivation-opportunity and transformational leadership in environment management: the mediating role of green culture by Rizvi, Yasmeen Shamsi, Garg, Raksha

“…PurposeManagers and management studies have for long assumed the separation of humans and nature that led to criticisms due to overexploitation of resources…”
Get full text

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers by DiPeri, Timothy P, Evans, Kurt W, Raso, Maria Gabriela, Zhao, Ming, Rizvi, Yasmeen Q, Zheng, Xiaofeng, Wang, Bailiang, Kirby, Bryce P, Kong, Kathleen, Kahle, Michael, Yap, Timothy A, Dumbrava, Ecaterina E, Ajani, Jaffer A, Fu, Siqing, Keyomarsi, Khandan, Meric-Bernstam, Funda

“…Cyclin E (CCNE1) has been proposed as a biomarker of sensitivity to adavosertib, a Wee1 kinase inhibitor, and a mechanism of resistance to HER2-targeted…”
Get full text

Serum Glucocorticoid-Regulated Kinase 1 Blocks CKD-Induced Muscle Wasting Via Inactivation of FoxO3a and Smad2/3 by Luo, Jinlong, Liang, Anlin, Liang, Ming, Xia, Ruohan, Rizvi, Yasmeen, Wang, Yun, Cheng, Jizhong

“…Muscle proteolysis in CKD is stimulated when the ubiquitin-proteasome system is activated. Serum glucocorticoid-regulated kinase 1 (SGK-1) is involved in…”
Get full text

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations by Pairawan, Seyed, Akcakanat, Argun, Kopetz, Scott, Tapia, Coya, Zheng, Xiaofeng, Chen, Huiqin, Ha, Min Jin, Rizvi, Yasmeen, Holla, Vijaykumar, Wang, Jing, Evans, Kurt W., Zhao, Ming, Busaidy, Naifa, Fang, Bingliang, Roth, Jack A., Dumbrava, Ecaterina Ileana, Meric-Bernstam, Funda

“…Most tumors with activating MAPK (mitogen-activated protein kinase) pathway alterations respond poorly to MEK inhibitors alone. Here, we evaluated combination…”
Get full text

Human Capital Development Role of HR during Mergers and Acqusitions by Rizvi, Yasmeen

Get full text

Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations by Shariati, Maryam, Evans, Kurt W., Zheng, Xiaofeng, Bristow, Christopher A., Ng, Patrick Kwok-Shing, Rizvi, Yasmeen Q., Tapia, Coya, Yang, Fei, Carugo, Alessandro, Heffernan, Timothy P., Peoples, Michael D., Tripathy, Debu, Meric-Bernstam, Funda

“…Molecular alterations in the PI3K/AKT pathway occur frequently in hormone receptor-positive breast tumors. Patients with ER-positive, HER2-negative metastatic…”
Get full text

From anthropocentrism to sustaincentrism: case study on beverage companies in India by Shamsi Rizvi, Yasmeen, Garg, Raksha

“…Business organizations have been facing an unprecedented level of criticisms for being one of the prime contributors to the deterioration of environmental…”
Get full text

A Novel Dual Kinase Function of the RET Proto-oncogene Negatively Regulates Activating Transcription Factor 4-mediated Apoptosis by Bagheri-Yarmand, Rozita, Sinha, Krishna M., Gururaj, Anupama E., Ahmed, Zamal, Rizvi, Yasmeen Q., Huang, Su-Chen, Ladbury, John E., Bogler, Oliver, Williams, Michelle D., Cote, Gilbert J., Gagel, Robert F.

“…The RET proto-oncogene, a tyrosine kinase receptor, is widely known for its essential role in cell survival. Germ line missense mutations, which give rise to…”
Get full text

Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer by Sinha, Krishna M., Bagheri-Yarmand, Rozita, Lahiri, Sharmistha, Lu, Yue, Zhang, Miao, Amra, Sarah, Rizvi, Yasmeen, Wan, Xinhai, Navone, Nora, Ozpolat, Bulent, Logothetis, Christopher, Gagel, Robert F., Huard, Johnny

“…Epigenetic changes that cause dysregulated gene expression during progression of androgen-independent prostate cancer (PCa) and metastatic skeletal lesions…”
Get full text

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts by DiPeri, Timothy P, Evans, Kurt W, Wang, Bailiang, Zhao, Ming, Akcakanat, Argun, Raso, Maria Gabriela, Rizvi, Yasmeen Q, Zheng, Xiaofeng, Korkut, Anil, Varadarajan, Kaushik, Uzunparmak, Burak, Dumbrava, Ecaterina E, Pant, Shubham, Ajani, Jaffer A, Pohlmann, Paula R, Jensen, V Behrana, Javle, Milind, Rodon, Jordi, Meric-Bernstam, Funda

“…Zanidatamab is a bispecific human epidermal growth factor receptor 2 (HER2)-targeted antibody that has demonstrated antitumor activity in a broad range of…”
Get more information

Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis by Rizvi, Yasmeen Q, Mehta, Chander S, Oyekan, Adebayo

“…Abstract Hypoxia and adenosine are known to upregulate angiogenesis; however, the role of peroxisome proliferator-activated receptor alpha (PPARα) in…”
Get full text

Corporate social responsibility and psychological capital during the COVID-19 pandemic: perspectives from India by Rizvi, Yasmeen Shamsi, Nabi, Asma

“…Purpose This paper aims to examine the relationship between employees’ perception of corporate social responsibility (CSR) practices in Indian business…”
Get full text

Transformation of Learning from Real to Virtual: An Exploratory-Descriptive Analysis of Issues and Challenges by Rizvi, Yasmeen Shamsi, Nabi, Asma

“…Purpose: As online teaching/learning is a new phenomenon with reference to regular degree programs in institutions of higher education in India (the situation…”
Get full text

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan by Zhao, Ming, DiPeri, Timothy P., Raso, Maria Gabriela, Zheng, Xiaofeng, Rizvi, Yasmeen Qamar, Evans, Kurt W., Yang, Fei, Akcakanat, Argun, Roberto Estecio, Marco, Tripathy, Debu, Dumbrava, Ecaterina E., Damodaran, Senthil, Meric-Bernstam, Funda

“…TROP2 antibody drug conjugates (ADCs) are under active development. We seek to determine whether we can enhance activity of TROP2 ADCs by increasing TROP2…”
Get full text

Learned Helplessness at the Workplace and Its Impact on Work Involvement: An Empirical Analysis by Rizvi, Yasmeen Shamsi, Sikand, Ratika

“…In today’s work environment that is characterized by rapid advancements in technology, globalization, liberalization, workforce diversity and increasing…”
Get full text

Abstract PS18-37: Loss of Trop2 protein in metaplastic carcinoma of breast by IHC by Yang, Fei, Rizvi, Yasmeen, Yuca, Erkan, Zhao, Ming, Evans, Kurt, Zheng, Xiaofeng, Sahin, Aysegul, Meric-Bernstam, Funda

“…Abstract Background: Trop2 (trophoblast cell surface antigen) is a transmembrane calcium transducer which has been associated with tumor growth, aggressiveness…”
Get full text

Utilizing Patient-derived Xenografts to Model Precision Oncology for Biliary Tract Cancer by DiPeri, Timothy P., Evans, Kurt W., Scott, Stephen, Zheng, Xiaofeng, Varadarajan, Kaushik, Kwong, Lawrence N., Kahle, Michael, Tran Cao, Hop S., Tzeng, Ching-Wei, Vu, Thuy, Kim, Sunhee, Su, Fei, Raso, Maria Gabriela, Rizvi, Yasmeen, Zhao, Ming, Wang, Huamin, Lee, Sunyoung S., Yap, Timothy A., Rodon, Jordi, Javle, Milind, Meric-Bernstam, Funda

“…Abstract Purpose: Biliary tract cancers (BTCs), which are rare and aggressive malignancies, are rich in clinically actionable molecular alterations. A major…”
Get full text

Heterogeneous Profile of ROR1 Protein Expression across Tumor Types by Raso, Maria Gabriela, Barrientos Toro, Elizve, Evans, Kurt, Rizvi, Yasmeen, Lazcano, Rossana, Akcakanat, Argun, Sini, Patrizia, Trapani, Francesca, Madlener, Eva Johanna, Waldmeier, Lorenz, Lazar, Alexander, Meric-Bernstam, Funda

“…The Wnt receptor ROR1 has generated increased interest as a cancer therapeutic target. Research on several therapeutic approaches involving this receptor is…”
Get full text

Interactions of peroxisome proliferator‐activated receptor alpha (PPARá) and adenosine receptors (AR) in angiogenesis by Rizvi, Yasmeen Q, Oyekan, Adebayo

“…Hypoxia (HYP) stimulates angiogenesis (ANG) by promoting expression of many pro‐angiogenic genes, including AR. The role of PPARα in ANG is controversial…”
Get full text

Abstract P058: Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations by Pico, Christian X. Cruz, Li, Dali, Lanier, Christopher D., Evans, Kurt, Raso, Maria G., DiPeri, Timothy, Rizvi, Yasmeen, Ha, Min Jin, Chen, Huiqin, Zhao, Ming, Akcakanat, Argun, Zheng, Xiaofeng, Toruner, Gokce, Yuca, Erkan, Scott, Stephen, Wengner, Antje M., Yap, Timothy A., Meric-Bernstam, Funda

“…Abstract Introduction: The ATR (ataxia-telangiectasia and Rad3 related protein) kinase inhibitor BAY 1895344 is currently in clinical development for the…”
Get full text